Seagen, Genmab gun for Merck’s Keytruda in cervical cancer with accelerated FDA nod for ADC therapy Tivdak

Seagen, Genmab gun for Merck’s Keytruda in cervical cancer with accelerated FDA nod for ADC therapy Tivdak
nhigginsdunn
Tue, 09/21/2021 – 10:07